Author:
Goonewardene Sanchia S.,Persad Raj,Albala David,Cahill Declan
Publisher
Springer International Publishing
Reference5 articles.
1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the Prisma statement. BMJ (Online). 2009;339(7716):332–6.
2. Mays N, Pope C, Popay J. Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field. J Health Serv Res Policy. 2005;10:6–20.
3. Sasaki H, Kido M, Miki K, et al. Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy. Int J Urol. 2014;21(6):572–7.
4. Lacy JM, Wilson WA, Bole R, et al. Salvage brachytherapy for biochemically recurrent prostate cancer following primary brachytherapy. Prostate Cancer. 2016;2016:9561494.
5. Girum KB, Lalande A, Quivrin M, et al. Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images. Brachytherapy. 2018;17(6):866–73.